CIBC Private Wealth Group
TTNP

CIBC Private Wealth Group’s Titan Pharmaceuticals TTNP Stock Holding History

CIBC Private Wealth Group’s Portfolio TTNP Stock Details TTNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Hold
0
– -$1K – 1669
2018
Q2 		– Hold
0
– – – 1915
2018
Q1 		– Hold
0
– – – 1883
2017
Q4 		– Hold
0
– – – 1886

Other funds holding TTNP

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
WPA
Winning Points Advisors Boca Raton, Florida $75.9M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return